Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Sophie ... Kallister ...

Mar 26, 2007 09:19AM

Mar 26, 2007 09:47AM

The real discussion should be about what our company has chosen to do with the revenue it has received. The court case is being handled by a strong team in TPL and I do have faith in their abilities. In our 1 correspondence from our rep he even stated how PTSC should be evaluated.

Quote: "The announced Licenses and the scrutiny of the audits to date should by now have left the ever present "scam" consideration behind us, even by the more skeptical of shareholders. Planning - Execution - Performance ... these are the scorecards which every management team and BOD should be judged; not by reactions induced through fear mongering or casually tossing around provocative words and sensationalized one liners."

Draining the treasury removes the potential for acquiring or developing our own technologies.

This is not planning. I do not believe this has been dismissed by potential investors and why the

buying interest is not with PTSC. I would have expected more buying interest by speculators in PTSC the closer we get to the markman. Our share price has declined, imo, because our management team has not planned, performed or executed. The buying interest last year was there for PTSC and fell apart after our sharehholder meeting because it was very clear, to at least

this investor, that our BOD was and has been weak.

Holocom may have some potential but they were a company that went bankrupt. A positive for

the Holocom deal is that, as far as I understand, our BOD is not managing them.

I am accused by some of my "BOD mantra". Why…because I question the decisions by the BOD. How else are we to judge our company? We have no products and have basically stated

we will not develop our technologies but would consider outsourcing, a partnership, or outright

sale. So where is the leadership? Handing out dividends. PTSC would look much more attractive to potential investors if they had $40-$50 million in the bank with the expectation

of more revenue and the needed capital to invest in our own technologies or acquire a company.

Things do take time but handing out all the money in divys is a contradiction to growing the

company for additional revenue streams.

I agree with Brain….judge the BOD on Planning, Execution and Performance. I would hope for a rational discussion on where the BOD has achieved a good mark on any of the 3 management criteria.

Best of luck,

teremoto


Mar 26, 2007 10:53AM
Share
New Message
Please login to post a reply